Dr. Veerle Bergink is the director of Mount Sinai’s Women’s Mental Health Center and is internationally renowned as an expert in the treatment of psychiatric disorders in women. She is a professor at the Department of Psychiatry and the Department of Obstetrics, Gynecology, and Reproductive Science at the Icahn School of Medicine at Mount Sinai. She received her PhD from Erasmus University Rotterdam in 2012. Since 2014, she has been involved in epidemiological studies at the Institute of Registered Research in Denmark, examining intergenerational psychopathology and medication use during pregnancy. She has been the principal investigator on multiple research projects, including studying COVID-19 during pregnancy, psychotropic medication use during pregnancy, neuroimaging of new mothers and their offspring, and the longitudinal course of severe perinatal mood disorders. Her research focuses on continued investigations into medication use during pregnancy; utero brain development; bipolar disorder; postpartum mania, psychosis, and depression; immunology; brain imaging; and epidemiology. She has published extensively in top-tier scientific journals. Two papers were listed as the top 10 most important clinical studies in the entire field of psychiatry, selected by the publishing group of the NEJM.
Dr. Rosalind J. Wright, MD, MPH, is the Dean for Public Health and Chair of the Department of Public Health. She is Co-Director of the Institute for Climate Change, Environmental Health, and Exposomics and Director of Conduits, the Clinical and Translational Science Award (CTSA) Program at Mount Sinai. She is an internationally recognized clinician–scientist and life course epidemiologist with transdisciplinary training in molecular biology, environmental health, and stress mechanisms. Her research has focused on the role of social risk and resiliency factors (e.g., psychosocial stress, social networks, socioeconomic factors) alone or with physical environmental factors (e.g., ambient air pollution, diet/nutrition, allergens, chemicals) in programming chronic disease risk. Her research has been supported by uninterrupted funding from the National Institutes of Health (NIH) for 23 years. She received a Bachelor of Science in human genetics and her medical degree from the University of Michigan. She was awarded the inaugural program for Scholars in Environmental Pediatrics, Reproductive Health, and Life Course Science K12 program funded by the National Institute of Environmental Health Sciences. She has served on numerous national and international committees. She is currently Co-Chair of the Steering Committee for the Precision Intervention for Severe or Exacerbation-Prone Asthma Network at the National Heart, Lung, and Blood Institute.
